2 hours ago
Moderna (MRNA) Stock Soars 13% on In Vivo CAR-T Breakthrough and Flu Vaccine Progress
Moderna (MRNA) stock surged 13% after revealing its CAR-T program for autoimmune diseases and securing a 9-0 FDA panel vote for its flu vaccine candidate.
The post Moderna (MRNA) Stock Soars 13% on In Vivo CAR-T Breakthrough and Flu Vaccine Progress appeared first on Blockonomi.
Source: Blockonomi →Related News
- 2 hours ago
Amazon (AMZN) Stock Climbs as AWS Implements Third Consecutive GPU Price Increas...
- 2 hours ago
Oracle (ORCL) Stock Plunges 19% in Worst Weekly Decline Since Dot-Com Era
- 2 hours ago
Micron (MU) Stock Soars 17% on Record Quarterly Results and $100B in Future Orde...
- 2 hours ago
Trump Vows 100% Tariffs on Nations Taxing U.S. Tech Giants
- 2 hours ago
Qualcomm (QCOM) Stock Rockets 15% After Meta Partnership and Aggressive Data Cen...